Drug intelligence / Profile preview

pomegranate juice extract

Development stage
Unknown
Lead developer
POM Wonderful
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Pomegranate juice extract is a concentrated preparation derived from the juice of Punica granatum fruit, standardized variably to polyphenols such as ellagitannins (notably punicalagin and punicalin) and anthocyanins. It is marketed as a dietary supplement for antioxidant, anti-inflammatory, cardiometabolic, and general wellness uses. Mechanistically, key constituents exhibit antioxidant and anti-inflammatory effects and have been reported to inhibit cytochrome P450 enzymes CYP3A4 and CYP2C9 in preclinical studies, raising potential for drug–herb interactions; limited human data suggest minimal clinically relevant CYP3A inhibition with single-dose juice, but case observations and preclinical findings indicate possible interactions with drugs metabolized by these enzymes. A randomized clinical study has explored 250 mg twice daily pomegranate extract for 8 weeks in mild-to-moderate allergic asthma, showing improvements in some clinical symptoms and reductions in certain granulocyte counts. Safety data indicate pomegranate juice is generally safe orally; pomegranate extract is possibly safe by mouth or topically, while root/stem/peel are unsafe in large amounts due to toxic constituents. Use during pregnancy and lactation is considered possibly safe for juice; insufficient data exist for extract forms, so caution is advised.

Other names
Punica granatum juice extractpomegranate extractPJ extract
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)

Beyond the preview

Go deeper on pomegranate juice extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pomegranate juice extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call